Publication | Closed Access

The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Baseline DiseaseUrologyGenitourinary CancerMedicineCancer ManagementOutcomes ResearchPharmacotherapyPrevail StudyProstatic DiseaseEnzalutamide-treated MenOncology